Center for Medical Weight Loss

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• Compounded semaglutideCompounded · not FDA-approved
• Ozempic (semaglutide)FDA-approved

What they publish

Center for Medical Weight Loss publishes 1 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

Compounded semaglutide plan published from $195/month on an annual plan, with a first month at $149; Ozempic plan published at $1,099/month (as published)

Medication cost

Not publicly disclosed on the pages we captured.

Introductory offer

$149 first month on the monthly semaglutide plan

Insurance

Not publicly disclosed on the pages we captured.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

Not publicly disclosed on the pages we captured.

Eligibility

Not publicly disclosed on the pages we captured.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

Not publicly disclosed on the pages we captured.

Shipping

Not publicly disclosed on the pages we captured.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

Not publicly disclosed on the pages we captured.

Refunds

Not publicly disclosed on the pages we captured.

What stands out

• Publishing both routes on one page with a $195 versus $1,099 spread is the clearest side-by-side in this directory.
• The $195 rate requires an annual plan; the monthly plan is priced differently.
• Offering the brand plan at all means the approved route is genuinely available rather than nominal.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• The $195 figure is tied to an annual commitment — establish the monthly-plan rate and the refund position.
• The two plans are not the same product: one is FDA-approved, one is not.
• Ask which pharmacy compounds the cheaper option and whether it is 503A or 503B.